HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Experimental Neoplasms

Subscribe to New Research on Experimental Neoplasms

Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.

Also Known As:

Neoplasms, Experimental; Experimental Neoplasm; Neoplasm, Experimental

Networked: 47 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Disease Context: Research Results

Neoplasms: 649836
- Experimental Neoplasms: 47

Related Diseases

1.	Liver Diseases (Liver Disease)
2.	Sarcoma (Soft Tissue Sarcoma)
3.	Neoplasms (Cancer)
4.	Necrosis
5.	Leukemia L1210

Experts

1.	Garnuszek, Piotr: 1 article (07/2008)
2.	Maurin, Michał: 1 article (07/2008)
3.	Karczmarczyk, Urszula: 1 article (07/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Experimental Neoplasms:

1.	NitrogenIBA 12/01/1978 - "In order to obtain aromatic nitrogen mustards with improved therapeutic index against experimental neoplasms, greater than 75 new compounds were synthetized and studied. " 07/01/1984 - "[Effect of nitrogen derivative of verrucarin E, VER-I, on biology and development of morphological, histochemical and histoenzymatic changes in experimental neoplasms in animals]."
2.	VER I (WER I)IBA 01/01/1980 - "[Studies on the effect of a new verucarin E analog WER I on the growth of experimental neoplasms]." 07/01/1984 - "[Effect of nitrogen derivative of verrucarin E, VER-I, on biology and development of morphological, histochemical and histoenzymatic changes in experimental neoplasms in animals]."
3.	PseudocholinesteraseIBA 01/01/1981 - "[Usefulness of serum pseudocholinesterase isoenzymes in acute and chronic liver diseases and neoplasms (experimental and clinical study)]."
4.	IsoenzymesIBA 01/01/1981 - "[Usefulness of serum pseudocholinesterase isoenzymes in acute and chronic liver diseases and neoplasms (experimental and clinical study)]."
5.	IodineIBA 09/01/1960 - "[Effect of large doses of iodine on experimental neoplasms]." 07/01/2008 - "An enhancement of the antitumor activity due to the multidose concomitant treatment with a combination of cytotoxic/cytostatic dichloroplatinum(II)-histamine and the attached iodine radionuclides was shown in the murine model of experimental neoplasm."
6.	DNA (Deoxyribonucleic Acid)IBA 06/01/1973 - "The induction of host resistance to FBJ-MSV cells by immunization with identical and independently-induced FBJ-MSV tumours established that FBJ-MSV cells possess common cell surface antigenic specificities in a manner analogous to those of experimental neoplasms induced by other oncogenic DNA and RNA viruses. " 03/01/1965 - "[The histospectrophotometric measurement of nuclear of DNA of an experimental neoplasm after antitumor blood prophylaxis]."
7.	Ascorbic Acid (Vitamin C)FDA LinkGeneric 02/15/1959 - "[Development of an experimental neoplasm in normal & adrenalectomized rats treated with vitamin C; experimental research on Galliera sarcoma]." 06/02/1957 - "[Changes in the development of an experimental neoplasm under treatment with vitamin C; experimental research on Galliera sarcoma]."
8.	purineIBA 07/01/1959 - "Structure-activity relationships and cross-resistance observed on evaluation of a series of purine analogs against experimental neoplasms." 05/01/1959 - "Structure-activity relationships and cross-resistance observed on evaluation of a series of purine analogs against experimental neoplasms."
9.	Cytostatic AgentsIBA 06/01/1971 - "[Experimental neoplasms induced by alkylating cytostatics and alkylating antibiotics]."
10.	Vincristine (Oncovin)FDA LinkGeneric 03/15/1987 - "It is suggested that it would be worthwhile to evaluate combinations of NSC 370147 and vincristine in tests with other experimental neoplasms."

Therapies and Procedures

1.	Immunotherapy 04/01/1979 - "[Immunotherapy of neoplasms--experimental studies]."
2.	Drug Therapy (Chemotherapy) 01/01/1988 - "A mathematical and computer-based model of alternating chemotherapy and radiation therapy in experimental neoplasms." 01/01/1984 - "T/R stem cells are primarily responsible for the failure of the best available chemotherapy to cure responsive, refractory, and very refractory experimental neoplasms. " 01/01/1999 - "[Glyciram as an enhancer of the effectiveness of chemotherapy and surgery in the treatment of experimental neoplasms]." 01/01/1974 - "[Prevention of immunosuppressive action of methotrexate during chemotherapy of experimental neoplasms]."
3.	Transplantation (Transplant Recipients) 06/15/1979 - "[Experimental neoplasm transplantation in the works of Polish physicians at the turn of the 19th century]."
4.	Lasers (Laser) 01/01/1977 - "[Immunologic reactivity of the body after laser irradiation of experimental neoplasms]."